In accordance with the Food and Drug Safety Administration's change order for drug manufacturing (import) product approval (Permission Review and Coordination Division-No. 2196, effective date 2010.05.07), the precautions for use of Lamiryl tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Lamiryl tablets
Attachments are original documents and may be in Korean. English editions are labeled separately.
Ramiryl tablets.hwpRamiryl tablets.hwp · 32 KBDownload ↓